These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1382801)

  • 1. Melanin, tyrosine hydroxylase, calbindin and substance P in the human midbrain and substantia nigra in relation to nigrostriatal projections and differential neuronal susceptibility in Parkinson's disease.
    Gibb WR
    Brain Res; 1992 May; 581(2):283-91. PubMed ID: 1382801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calretinin and calbindin-D28k in dopaminergic neurons of the rat midbrain: a triple-labeling immunohistochemical study.
    Nemoto C; Hida T; Arai R
    Brain Res; 1999 Oct; 846(1):129-36. PubMed ID: 10536220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparing of the dopaminergic neurons containing calbindin-D28k and of the dopaminergic mesocortical projections in weaver mutant mice.
    Gaspar P; Ben Jelloun N; Febvret A
    Neuroscience; 1994 Jul; 61(2):293-305. PubMed ID: 7969910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The substantia nigra of the human brain. I. Nigrosomes and the nigral matrix, a compartmental organization based on calbindin D(28K) immunohistochemistry.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1421-36. PubMed ID: 10430829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organization of midbrain projections to the striatum in the primate: sensorimotor-related striatum versus ventral striatum.
    Lynd-Balta E; Haber SN
    Neuroscience; 1994 Apr; 59(3):625-40. PubMed ID: 7516506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
    Liang CL; Sinton CM; German DC
    Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The organization of midbrain projections to the ventral striatum in the primate.
    Lynd-Balta E; Haber SN
    Neuroscience; 1994 Apr; 59(3):609-23. PubMed ID: 7516505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems.
    Gerfen CR; Baimbridge KG; Thibault J
    J Neurosci; 1987 Dec; 7(12):3935-44. PubMed ID: 2891800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.
    Gerfen CR; Herkenham M; Thibault J
    J Neurosci; 1987 Dec; 7(12):3915-34. PubMed ID: 2891799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axonal expression sites of tyrosine hydroxylase, calretinin- and calbindin-immunoreactivity in striato-pallidal and septal nuclei of the rat brain: a double-immunolabelling study.
    Seifert U; Härtig W; Grosche J; Brückner G; Riedel A; Brauer K
    Brain Res; 1998 Jun; 795(1-2):227-46. PubMed ID: 9622641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of calbindin D28K in the dopaminergic mesotelencephalic system in embryonic and fetal human brain.
    Verney C; Zecevic N; Ezan P
    J Comp Neurol; 2001 Jan; 429(1):45-58. PubMed ID: 11086288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey.
    Smith Y; Charara A; Parent A
    J Comp Neurol; 1996 Jan; 364(2):231-53. PubMed ID: 8788247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoarchitectural distribution of calcium binding proteins in midbrain dopaminergic regions of rats and humans.
    McRitchie DA; Hardman CD; Halliday GM
    J Comp Neurol; 1996 Jan; 364(1):121-50. PubMed ID: 8789281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neurons expressing calbindin in normal and parkinsonian monkeys.
    Lavoie B; Parent A
    Neuroreport; 1991 Oct; 2(10):601-4. PubMed ID: 1684519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of alkaline phosphatase in situ hybridization with immunohistochemistry: colocalization of calretinin-mRNA with calbindin and tyrosine hydroxylase immunoreactivity in rat substantia nigra neurons.
    Heppelmann B; Señaris R; Emson PC
    Brain Res; 1994 Jan; 635(1-2):293-9. PubMed ID: 7909717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nigrostriatal pathway in the rat: A single-axon study of the relationship between dorsal and ventral tier nigral neurons and the striosome/matrix striatal compartments.
    Prensa L; Parent A
    J Neurosci; 2001 Sep; 21(18):7247-60. PubMed ID: 11549735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationship of the distribution of neuropeptides and tyrosine hydroxylase immunoreactivity in the human substantia Nigra.
    Haber SN; Groenewegen HJ
    J Comp Neurol; 1989 Dec; 290(1):53-68. PubMed ID: 2480370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between neuromelanin and dopamine terminals within the Parkinson's nigrostriatal system.
    Martín-Bastida A; Lao-Kaim NP; Roussakis AA; Searle GE; Xing Y; Gunn RN; Schwarz ST; Barker RA; Auer DP; Piccini P
    Brain; 2019 Jul; 142(7):2023-2036. PubMed ID: 31056699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K.
    Yamada T; McGeer PL; Baimbridge KG; McGeer EG
    Brain Res; 1990 Sep; 526(2):303-7. PubMed ID: 2257487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.